SCHEMBL13124402

SCHEMBL13124402

O=C(c1csc(COc2ccccc2)c1)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.50
ALDH1A1 P00352 6/20 0.50
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPK1 P28482 1/20 0.50
TP53 P04637 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 1/20 0.48
MAPT P10636 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
USP2 O75604 1/20 0.46
KCNA5 P22460 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664121 0.83 HPGD (0.52) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13124412 0.81 MEN1 (0.49) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13124415 0.80 HPGD (0.60) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13124410 0.80 HRH3 (0.53) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3664813 0.77 HPGD (0.62) HPGDALDH1A1MAPK1TP53RECQL
SCHEMBL13125173 0.77 HPGD (0.52) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL15420889 0.75 NPC1 (0.76) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12911826 0.73 HPGD (0.58) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL939431 0.73 HPGD (0.58) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3802648 0.73 HPGD (0.48) HPGDALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362008-B2 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors THE UNIVERSITY OF EDINBURGH (GB) 2013-01-29 US disclosed
US-8362008-B2 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors THE UNIVERSITY OF EDINBURGH (GB) 2013-01-29 US disclosed
US-20100267696-A1 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors THE UNIVERSITY OF EDINBURGH 2010-10-21 US disclosed
US-20100267696-A1 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors THE UNIVERSITY OF EDINBURGH 2010-10-21 US disclosed
WO-2009074789-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS THE UNIVERSITY OF EDINBURGH (GB) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267696-A1 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors HSD11B1, HSD11B2, HSD17B1 HPGD 190/4885ALDH1A1 285/4885NPC1 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.